Publikace UTB
Repozitář publikační činnosti UTB
Karcinom prsu u mužů
Repozitář DSpace/Manakin
Kontaktujte nás | Jazyk: čeština English
- Domovská stránka DSpace
- →
- Recenzovaný odborný článek
- →
- Fakulta humanitních studií
- →
- Zobrazit záznam
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.title | Karcinom prsu u mužů | cs |
| dc.title | Male breast cancer | en |
| dc.contributor.author | Gatěk, Jiří | |
| dc.contributor.author | Duben, Jiří | |
| dc.contributor.author | Dudešek, Bohumil | |
| dc.contributor.author | Ratajský, Martin | |
| dc.contributor.author | Holík, Pavel | |
| dc.contributor.author | Zábojníková, Michaela | |
| dc.contributor.author | Vrána, David | |
| dc.relation.ispartof | Onkologie (Czech Republic) | |
| dc.identifier.issn | 1802-4475 Scopus Sources, Sherpa/RoMEO, JCR | |
| dc.identifier.issn | 1803-5345 Scopus Sources, Sherpa/RoMEO, JCR | |
| dc.date.issued | 2020 | |
| utb.relation.volume | 14 | |
| utb.relation.issue | Suppl. E | |
| dc.citation.spage | 106 | |
| dc.citation.epage | 111 | |
| dc.type | article | |
| dc.language.iso | cs | |
| dc.publisher | SOLEN s.r.o. | |
| dc.identifier.doi | 10.36290/xon.2020.066 | |
| dc.relation.uri | www.onkologiecs.cz/artkey/xon-202092-0002_karcinom_prsu_u_muzu.php | |
| dc.subject | adjuvant therapy | en |
| dc.subject | epidemiology | en |
| dc.subject | male cancer | en |
| dc.subject | surgery | en |
| dc.description.abstract | Male breast cancer is rare disease and it represents 1 % breast cancer. Invasive ductal cancer dominates in histology with 10 % portion in situ carcinoma. Other histology types are extraordinary. Female breast carcinoma has different diversion in molecular subtype than male carcinoma, which is predominant hormonal sensitive. Mastectomy is procedure of choice with sentinel node biopsy or axillary dissection in surgery. Radiotherapy is used after breast conservative procedure. Indication after mastectomy depends on stage of the carcinoma. Hormonal therapy is mainly applied in adjuvant therapy and mostly with Tamoxifen. Male carcinoma is very similar with female carcinoma but is not identical. Medical care come out from experience with treatment female carcinoma. Contemporary knowledge about male carcinoma needs new trials oriented on male carcinoma. © 2020 SOLEN s.r.o.. All rights reserved. | en |
| utb.faculty | Faculty of Humanities | |
| utb.faculty | Library | |
| dc.identifier.uri | http://hdl.handle.net/10563/1010419 | |
| utb.identifier.obdid | 43883388 | |
| utb.identifier.scopus | 2-s2.0-85108578362 | |
| utb.source | j-scopus | |
| dc.date.accessioned | 2021-07-09T11:31:06Z | |
| dc.date.available | 2021-07-09T11:31:06Z | |
| utb.contributor.internalauthor | Gatěk, Jiří | |
| utb.contributor.internalauthor | Holík, Pavel | |
| utb.fulltext.affiliation | Jiří Gatěk1, 2, Jiří Duben1 , Bohumil Dudešek1 , Martin Ratajský1 , Pavel Holík2, 3, Michaela Zábojníková4, David Vrána5 1 Chirurgické oddělení EUC klinika Zlín 2 Univerzita Tomáše Bati ve Zlíně 3 Knihovna, Univerzita Tomáše Bati ve Zlíně 4 Onkologické oddělení KTNB Zlín 5 Onkologické oddělení Nemocnice Nový Jičín | |
| utb.fulltext.dates | Článek přijat redakcí: 23. 4. 2020 Článek přijat k publikaci: 7. 6. 2020 | |
| utb.fulltext.references | 1. Javidiparsijani S, Rosen LE, Gattiso P. Male Breast Carcinoma: A Clinical and Pathological Review. International Journal of Surgical Pathology 2017; (23): 200–205 doi.org/10.1177/1066896916675953. 2. Giordano SH. N Engl J Med. Breast Cancer in Men. 2018; (378): 2311–2320. doi: 10.1056/NEJMra1707939. 3. Korde LA, Zujewski A, Kamin L, et al. Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations. J Clin Oncol. 2010; (28): 2114–2122. doi: 10.1200/JCO.2009.25.5729. 4. Bielčíková Z. Karcinom prsu u mužů. Onkologie. 2016; (10): 170–174. 5. Weiss JR, Moysich, Swede H. Epidemiology of Male Breast Cancer. Cancer epidemiol Biomarkers Prev 2005; (14): 20–26. 6. Abdelwahab Yousef AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol 2017; (44): 267–272. doi: 10.1053/j.seminoncol.2017.11.002. 7. Ying WL, Agrawal A, Cheung KL. The ‘other half’ of breast cancer: A review of male breast cancer. The Journal of Men's Health & Gender 2005; (2): 406–413 https://doi.org/10.1016/j.jmhg.2005.10.012. 8. Leon-Ferre RA, Giridhar KV, Hieken TJ, et al. A contemporary review of male breast cancer: current evidence and unanswered questions. Cancer Metastasis Rev. 2018; (37): 599–614. doi: 10.1007/s10555–018–9761-x. 9. Coopey SB, Kartal K, Li C, et al. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019; (175): 1–4. doi: 10.1007/s10549–018–05117–4. 10. Krause W. Male breast cancer-an andrological disease: risk factors and diagnosis. Andrologie 2004; (36): 346–354. 11. Giordano SH, Perkins GH, Broglio K et al Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005; (104): 2359–2364. 12. Senger JL, Adams SJ, Rani KanthanR et al. Invasive lobular carcinoma of the male breast – a systematic review with an illustrative case study Breast Cancer 2017; (9): 337–345. doi: 10.2147/BCTT.S126341. 13. Adams SJ, Kanthan R. Paget's disease of the male breast in the 21st century: A systematic review. Breast. 2016; (29): 14–23. doi: 10.1016/j.breast.2016.06.015. 14. Gucalp A, Traina TA, Eisner JR, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019; (173): 37–48. doi: 10.1007/s10549–018–4921–9. 15. Johansson, Nilsson C, Berglund P, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Research. 2012; (14): R31. 16. Johansson Nilsson C, Berglund P, et al. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similar with female breast cancer. Breast Res Treat 2011; (3): 747–760. 17. Vermeulen MA, Slaets L, Cardoso F, et al. Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Eur J Cancer. 2017; (82): 219–227. doi: 10.1016/j.ejca.2017.01.034. 18. Cardoso F, Bartlett JMS, Slaets L, et al, Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. 2018; (29): 405–417. doi: 10.1093/annonc/mdx651. 19. Vincent F. Guinee VF, Shallenberger RC, Olsson H. The prognosis of breast cancer in males a report of 335 cases Cancer. 1993; (71): 154–161. https://doi.org/10.1002/1097–0142(19930101)71:1,154 | |
| utb.fulltext.sponsorship | - | |
| utb.scopus.affiliation | Chirurgické oddělení EUC klinika Zlín, a. s., Fügnerovo nábřeží 5 476, Zlín, 760 01, Czech Republic; Univerzita Tomáše Bati ve Zlíně, Czech Republic; Knihovna, Univerzita Tomáše Bati ve Zlíně, Czech Republic; Onkologické oddělení KTNB Zlín, Czech Republic; Onkologické oddělení Nemocnice Nový Jičín, Czech Republic | |
| utb.fulltext.projects | - | |
| utb.fulltext.faculty | Library |
